Skip to main content
Presentation
MAGE-A3 or NY-ESO1 Expression and Spontaneous Antibody Responses to NY-ESO1 in Newly Diagnosed Multiple Myeloma Patients Are Associated with Worse Overall Survival
Blood (2008)
  • Adam D Cohen, Memorial Sloan Kettering Cancer Center
  • Ping Lu, Memorial Sloan Kettering Cancer Center
  • Sacha Gnjatic, Memorial Sloan Kettering Cancer Center
  • James Hoffman, Memorial Sloan Kettering Cancer Center
  • Erika Ritter, Memorial Sloan Kettering Cancer Center
  • Ping Zhou, Memorial Sloan Kettering Cancer Center
  • Julie Teruya-Feldstein, Memorial Sloan Kettering Cancer Center
  • Jodie Tassello, Memorial Sloan Kettering Cancer Center
  • Nicole Hanson, Memorial Sloan Kettering Cancer Center
  • Denise Frosina, Memorial Sloan Kettering Cancer Center
  • Achim Jungbluth, Memorial Sloan Kettering Cancer Center
  • Guenther Koehne, Memorial Sloan Kettering Cancer Center
  • Hani Hassoun, Memorial Sloan Kettering Cancer Center
  • Suresh Jhanwar, Memorial Sloan Kettering Cancer Center
  • Heather Landau, Memorial Sloan Kettering Cancer Center
  • Stephen Nimer, Memorial Sloan Kettering Cancer Center
  • Raymond L. Comenzo, Memorial Sloan Kettering Cancer Center
Publication Date
November 16, 2008
Citation Information
Adam D Cohen, Ping Lu, Sacha Gnjatic, James Hoffman, et al.. "MAGE-A3 or NY-ESO1 Expression and Spontaneous Antibody Responses to NY-ESO1 in Newly Diagnosed Multiple Myeloma Patients Are Associated with Worse Overall Survival" Blood (2008)
Available at: http://works.bepress.com/guenther-koehne/139/